# EDGAR Filing Document

**Accession Number:** 0001160330
**File Stem:** 0001292814-26-002128
**Filing Date:** 2026-4
**Character Count:** 6869
**Document Hash:** fb692a5215745574e2d11b098bb26f8a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001292814-26-002128.hdr.sgml**: 20260407

**ACCESSION NUMBER**: 0001292814-26-002128

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260630

**FILED AS OF DATE**: 20260407

**DATE AS OF CHANGE**: 20260406

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BANK BRADESCO
- **CENTRAL INDEX KEY:** 0001160330
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231
- **LEGAL ENTITY IDENTIFIER:** 551136842778

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15250
- **FILM NUMBER:** 26842421

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** CIDADE DE DEUS S/N VILA YARA
- **CITY:** SAO PAULO
- **PROVINCE COUNTRY:** D5
- **ZIP:** 06029-900
- **BUSINESS PHONE:** 551136842778

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** CIDADE DE DEUS S/N VILA YARA
- **CITY:** SAO PAULO
- **PROVINCE COUNTRY:** D5
- **ZIP:** 06029-900

------

**UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934** 

**For the month of April, 2026** **Commission File Number 1-15250** 

------

**BANCO BRADESCO S.A.** 

**(Exact name of registrant as specified in its charter)** 

**BANK BRADESCO** 

**(Translation of Registrant's name into English)** 

**Cidade de Deus, s/n, Vila Yara<br>06029-900 - Osasco - SP<br>Federative Republic of Brazil** 

**(Address of principal executive office)** 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____

.

![](bbd202604066k_001.jpg)

**Update on the Corporate Reorganization to Consolidate the Healthcare Businesses of Bradesco Organization in Odontoprev**

**Banco Bradesco S.A.** ("<u>Bradesco</u>"), in continuance to the Material Fact disclosed on February 27, 2026 and the Notice to the Market disclosed on March 6, 2026, related to the consolidation of the healthcare businesses of the Bradesco Organization in Odontoprev S.A. ("<u>Odontoprev</u>" and "<u>Transaction</u>"), hereby informs its shareholders and the market in general that, on the date hereof, the Extraordinary General Shareholders' Meetings of Odontoprev and Bradesco Gestão de Saúde S.A. ("<u>BGS</u>") were held, at which the following were approved, among other related matters: the merger of shares of BGS by Odontoprev ("<u>Merger of Shares</u>") and the contribution of operating assets and liabilities of Odontoprev to Mediservice Operadora de Planos de Saúde S.A. ("<u>Asset Contribution</u>" and "<u>Mediservice</u>").

It is also highlighted that all conditions precedent set forth in the "Protocol and Justification for the Merger of Shares of Bradesco Gestão de Saúde S.A. by Odontoprev S.A.", as amended and consolidated, have been duly satisfied, including the authorizations by the National Supplementary Health Agency ("<u>ANS</u>") on March 30, 2026, for the implementation of the Merger of Shares, and on April 2, 2026, for the consummation of the Asset Contribution.

Subject to ratification by the Boards of Directors of Odontoprev and BGS, the Merger of Shares shall become effective on April 30, 2026, therefore prior to the expiration of the period for (and with the waiver by the Board of Directors of Odontoprev of the reconsideration of the Transaction by reason of) the exercise of the withdrawal right by its dissenting shareholders.

Without prejudice to further details contained in the disclosures made by Odontoprev, Bradesco will keep its shareholders and the market in general informed of any material developments related to the Transaction, pursuant to the applicable regulations.

Cidade de Deus, Osasco, SP, April 6, 2026.

Banco Bradesco S.A.

**André Costa Carvalho**<br> *Investor Relations Officer*

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 6, 2026

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BANCO BRADESCO S.A.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BANCO BRADESCO S.A.  |
| By: | /S/André Costa Carvalho <br>|
|  | **André Costa Carvalho**<br>**Investor Relations Officer** |

---

**FORWARD-LOOKING STATEMENTS** 

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

------